High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancer
Meng Zhang,1 Xiaoli Li,1,2 Zhirui Fan,1 Jing Zhao,1 Shuzheng Liu,3 Mingzhi Zhang,1 Huixiang Li,4 Mariusz Adam Goscinski,5 Huijie Fan,1 Zhenhe Suo1,2,6 1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan Province, China; 2Department...
Main Authors: | Zhang M, Li X, Fan Z, Zhao J, Liu S, Li H, Goscinski MA, Fan H, Suo Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-05-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/high-srpx2-protein-expression-predicts-unfavorable-clinical-outcome-in-peer-reviewed-article-OTT |
Similar Items
-
SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma
by: Ampudia-Mesias, E., et al.
Published: (2022) -
SRPX2 knockdown inhibits cell proliferation and metastasis and promotes chemosensitivity in esophageal squamous cell carcinoma
by: Fei He, et al.
Published: (2019-01-01) -
SRPX2 Promotes Cell Proliferation and Invasion in Osteosarcoma Through Regulating Hippo Signaling Pathway
by: Wu Z, et al.
Published: (2020-02-01) -
SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis
by: Gao Zhenyuan, et al.
Published: (2020-10-01) -
Hepsin immunohistochemical expression in prostate cancer in relation to Gleason′s grade and serum prostate specific antigen
by: Madhu Mati Goel, et al.
Published: (2011-01-01)